Novartis is partnering with the American Society of Hematology (ASH) to roll out an app in six sub-Saharan African…
Articles by Margarida Maia, PhD
The total lifetime medical costs of living with sickle cell disease (SCD) total about $1.6 million for women and…
A renowned stem cell biologist has been honored with the 2022 Canada Gairdner International Award for his work that…
An enzyme known to play a key role in blood vessel health is present at low levels in the cells…
A researcher will use a four-year, $1.63 million grant from the National Institutes of Health (NIH) to help set…
Adakveo (crizanlizumab), by Novartis, is now available on the U.K.’s National Health Service (NHS) for sickle cell disease (SCD)…
Biopharmaceutical company Brooklyn ImmunoTherapeutics has launched a new center focused on research and development (R&D) of gene editing and…